Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ameren (AEE) EBITDA (2016 - 2026)

Ameren has reported EBITDA over the past 17 years, most recently at $271.0 million for Q4 2025.

  • For Q4 2025, EBITDA rose 28.44% year-over-year to $271.0 million; the TTM value through Dec 2025 reached $1.5 billion, up 24.26%, while the annual FY2025 figure was $1.5 billion, 24.11% up from the prior year.
  • EBITDA for Q4 2025 was $271.0 million at Ameren, down from $640.0 million in the prior quarter.
  • Over five years, EBITDA peaked at $640.0 million in Q3 2025 and troughed at $134.0 million in Q4 2021.
  • A 5-year average of $293.3 million and a median of $258.5 million in 2024 define the central range for EBITDA.
  • On a YoY basis, EBITDA climbed as much as 58.39% in 2021 and fell as far as 15.57% in 2021.
  • Year by year, EBITDA stood at $134.0 million in 2021, then rose by 11.19% to $149.0 million in 2022, then grew by 5.37% to $157.0 million in 2023, then skyrocketed by 34.39% to $211.0 million in 2024, then increased by 28.44% to $271.0 million in 2025.
  • Business Quant data shows EBITDA for AEE at $271.0 million in Q4 2025, $640.0 million in Q3 2025, and $273.0 million in Q2 2025.